IL-17-mediated transfection methods

Details for Australian Patent Application No. 2009302113 (hide)

Owner NovImmune SA

Inventors Elson, Greg; Contie, Mathias; Fouque, Nicolas; Leger, Olivier; Poitevin, Yves

Agent Cullens

Pub. Number AU-A-2009302113

PCT Pub. Number WO2010/041145

Priority 61/195,436 07.10.08 US

Filing date 7 October 2009

Wipo publication date 15 April 2010

International Classifications

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/041145 Priority application(s): WO2010/041145

9 June 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 05 May 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009302116-Communications cable and method of making same

2009302111-Oral vaccines for producing mucosal immunity